Artificial Intelligence (AI) in Biotechnology Market Size, Share, Growth Analysis, By Offering(Software, Hardware, Services), By Applications(Drug Target Identification, Drug Screening, Image Screening, Predictive Modeling), By Usage(Agriculture Biotechnology, Medical Biotechnology, Animal Biotechnology, Industrial Biotechnology), By Geography(North America, Europe, Asia-Pacific, Latin America) - Industry Forecast 2024-2031

The market for Artificial Intelligence (AI) in Biotechnology was estimated to be valued at US$ XX Mn in 2021.

The Artificial Intelligence (AI) in Biotechnology Market is estimated to grow at a CAGR of XX% by 2028.

The Artificial Intelligence (AI) in Biotechnology Market is segmented on the basis of Offering, Applications, Usage, Geography.

Based on region, the Artificial Intelligence (AI) in Biotechnology Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Artificial Intelligence (AI) in Biotechnology Market are AstraZeneca, Bristol-Myers Squibb, Gilead Sciences, Inc. , Sanofi, Abbott Laboratories, Biogen, Pfizer, Inc., Novo Nordisk A/S, Amgen, Inc., Merck KGaA, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Novartis AG.